"The findings uncover a new way in which the immune system is suppressed, limiting T cells from fighting cancer spread. This ...

Scientists share how they discovered that aspirin could potentially help to prevent cancer spread in the body.

A2 thromboxane A2; Nrf2, nuclear factor erythroid 2 related factor 2. ARE, antioxidant response element; ERK, extracellular regulated protein kinases; JNK, c-Jun N-terminal kinase; P38, ...

Williams explores groundbreaking research revealing how a simple aspirin pill could be a game-changer in cancer prevention, revolutionising treatment methods with its surprising effectiveness against ...

University of Cambridge scientists have described the “Eureka moment” when they discovered the mechanism behind how aspirin ...

A team of researchers from the University of Cambridge believe they have uncovered the mechanism behind how aspirin, a common and inexpensive painkiller, might be able to stop cancer from spreading – ...

Could aspirin keep cancer from spreading? A new study from the University of Cambridge suggests that the common pain ...

Their study focused on a substance called thromboxane A2 (TXA2), produced by blood cells known as platelets. They found that TXA2 triggers a reaction in the immune system, rendering T cells—key ...

This breakthrough paves the way for more accessible and targeted treatments. Aspirin works by inhibiting the production of thromboxane A2 (TXA2), a molecule produced by blood platelets. TXA2, known ...

The Cambridge team tested this idea by looking for the factors that shrink or boost immune defense. Their work drew attention to thromboxane A2, often called TXA2, which is produced by platelets. The ...

The scientists traced signals in the cell to determine that ARHGEF1 is switched on when T cells are exposed to a clotting factor called thromboxane A2 (TXA2). This was an unexpected revelation ...